We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
Turnover
31.08%
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
+24.48%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$72.6B
AUM Growth
+$8.69B
(+14%)
Cap. Flow
+$958M
Cap. Flow % of AUM
Cap. Flow %
1.32%
Top 10 Holdings %
Top 10 Hldgs %
12.01%
Holding
3,761
New
548
Increased
1,084
Reduced
1,502
Closed
621
Avg Time Held
3.5
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.58% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
Vulcan Infrastructure and Power
VIP
$23.6M
| $180K | ﹤0.01% |
100,300
+12,000
| +14% | +$16.3K |
2025 Q3
3 quarters
|
|
2902
Independence Realty Trust
IRT
$3.5B
| $178K | ﹤0.01% |
+10,695
| New | +$173K |
2026 Q2
0 quarters
|
|
2903
Ashford Hospitality Trust
AHT
$11.6M
| $178K | ﹤0.01% |
54,803
-1,500
| -3% | -$4.48K |
2022 Q1
17 quarters
|
|
2904
NanoViricides
NNVC
$37.8M
| $177K | ﹤0.01% |
128,600
-6,300
| -5% | -$8.64K |
2021 Q4
18 quarters
|
|
2905
Lipocine
LPCN
$13.4M
| $177K | ﹤0.01% |
69,209
+30,712
| +80% | +$73.9K |
2022 Q1
17 quarters
|
|
2906
Beta Bionics
BBNX
$957M
| $177K | ﹤0.01% |
+11,300
| New | +$134K |
2026 Q2
0 quarters
|
|
2907
Avalon Holdings
AWX
$10.2M
| $176K | ﹤0.01% |
70,810
-5,172
| -7% | -$13.1K |
2019 Q4
26 quarters
|
|
2908
Summit State Bank
SSBI
$81.1M
| $175K | ﹤0.01% |
12,890
+300
| +2% | +$4.08K |
2025 Q4
2 quarters
|
|
2909
Simply Good Foods
SMPL
$972M
| $174K | ﹤0.01% |
13,100
-109,900
| -89% | -$1.36M |
2025 Q2
4 quarters
|
|
2910
Tvardi Therapeutics
TVRD
$13.2M
| $174K | ﹤0.01% |
91,409
-691
| -0.8% | -$2.17K |
2023 Q1
13 quarters
|
|
2911
Guardforce AI
GFAI
$6.94M
| $172K | ﹤0.01% |
432,100
+36,900
| +9% | +$17.8K |
2024 Q3
7 quarters
|
|
2912
electroCore
ECOR
$67.5M
| $172K | ﹤0.01% |
19,900
-24,509
| -55% | -$183K |
2020 Q4
22 quarters
|
|
2913
Boston Omaha
BOC
$379M
| $169K | ﹤0.01% |
+12,400
| New | +$156K |
2026 Q2
0 quarters
|
|
2914
Core Laboratories
CLB
$462M
| $169K | ﹤0.01% |
14,500
-36,103
| -71% | -$515K |
2025 Q3
3 quarters
|
|
2915
AMTD Digital
HKD
$541M
| $169K | ﹤0.01% |
106,158
+14,358
| +16% | +$24.4K |
2025 Q2
4 quarters
|
|
2916
TOYO Co
TOYO
$171M
| $168K | ﹤0.01% |
24,200
-21,800
| -47% | -$268K |
2025 Q3
3 quarters
|
|
2917
Playboy Inc
PLBY
$135M
| $168K | ﹤0.01% |
137,800
-287,559
| -68% | -$436K |
2024 Q3
7 quarters
|
|
2918
Anixa Biosciences
ANIX
$93.2M
| $166K | ﹤0.01% |
59,373
-1,800
| -3% | -$5.01K |
2024 Q3
7 quarters
|
|
2919
VistaGen Therapeutics
VTGN
$8.78M
| $165K | ﹤0.01% |
730,500
+439,200
| +151% | +$265K |
2024 Q1
9 quarters
|
|
2920
P3 Health Partners
PIII
$15.5M
| $164K | ﹤0.01% |
+15,149
| New | +$113K |
2026 Q2
0 quarters
|
|
2921
Beeline Holdings
BLNE
$21.7M
| $159K | ﹤0.01% |
130,695
+113,739
| +671% | +$187K |
2025 Q3
3 quarters
|
|
2922
Willamette Valley Vineyards
WVVI
$9.8M
| $159K | ﹤0.01% |
63,352
-2,700
| -4% | -$7.29K |
2013 Q3
51 quarters
|
|
2923
Destination XL Group
DXLG
$25.3M
| $159K | ﹤0.01% |
237,272
-51,500
| -18% | -$33.9K |
2022 Q3
15 quarters
|
|
2924
NRX Pharmaceuticals
NRXP
$113M
| $158K | ﹤0.01% |
+38,600
| New | +$128K |
2026 Q2
0 quarters
|
|
2925
Mannatech
MTEX
$15.9M
| $157K | ﹤0.01% |
30,078
-800
| -3% | -$4.15K |
2018 Q3
31 quarters
|
|
Similar funds
Jim Simons's Q2 2026 Portfolio in Review
As of Q2 2026, Jim Simons held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Jim Simons added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Jim Simons's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Jim Simons fully exited Applovin in Q2 2026, selling an estimated $174M.
- Jim Simons's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Jim Simons opened 548 new positions and closed 621 in Q2 2026.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.